SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ian M. Bell, Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine, Journal of Medicinal Chemistry, 2014, 140626103424004

    CrossRef

  2. 2
    R.J. Benschop, E.C. Collins, R.J. Darling, B.W. Allan, D. Leung, E.M. Conner, J. Nelson, B. Gaynor, J. Xu, X.-F. Wang, R.A. Lynch, B. Li, D. McCarty, J.L. Oskins, C. Lin, K.W. Johnson, M.G. Chambers, Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain, Osteoarthritis and Cartilage, 2014, 22, 4, 578

    CrossRef

  3. 3
    Marcelo E. Bigal, Sarah Walter, Alan M. Rapoport, Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development, Headache: The Journal of Head and Face Pain, 2013, 53, 8
  4. 4
    Sieneke Labruijere, Khatera Ibrahimi, Kayi Y Chan, Antoinette MaassenVanDenBrink, Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies, Expert Opinion on Drug Discovery, 2013, 8, 11, 1309

    CrossRef

  5. 5
    K Ibrahimi, AHJ Danser, CM Villalón, AH van den Meiracker, A MaassenVanDenBrink, Influence of varying estrogen levels on trigeminal CGRP release in healthy women, The Journal of Headache and Pain, 2013, 14, Suppl 1, P123

    CrossRef

  6. 6
    Thomas P Bravo, Bert B Vargas, Rashmi B Halker, Novel Approaches in Migraine Treatment, 2013,

    CrossRef

  7. 7
    B R Chaitman, A P Ho, M O Behm, J F Rowe, J S Palcza, T Laethem, I Heirman, D L Panebianco, Z Kobalava, S Y Martsevich, A L Free, N Bittar, S G Chrysant, T W Ho, J A Chodakewitz, M G Murphy, R L Blanchard, A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina, Clinical Pharmacology & Therapeutics, 2012, 91, 3, 459

    CrossRef

  8. 8
    Pierangelo Geppetti, Eleonora Rossi, Alberto Chiarugi, Silvia Benemei, Antidromic vasodilatation and the migraine mechanism, The Journal of Headache and Pain, 2012, 13, 2, 103

    CrossRef

  9. 9
    Lars Edvinsson, Mattias Linde, CGRP antagonists for the treatment of migraine: rationale and clinical data, Clinical Investigation, 2012, 2, 1, 73

    CrossRef

  10. 10
    Ian M. Bell, Craig A. Stump, Steven N. Gallicchio, Donnette D. Staas, C. Blair Zartman, Eric L. Moore, Nova Sain, Mark Urban, Joseph G. Bruno, Amy Calamari, Amanda L. Kemmerer, Scott D. Mosser, Christine Fandozzi, Rebecca B. White, Matthew M. Zrada, Harold G. Selnick, Samuel L. Graham, Joseph P. Vacca, Stefanie A. Kane, Christopher A. Salvatore, MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 12, 3941

    CrossRef

  11. 11
    Noboru Toda, Kazuhide Ayajiki, Tomio Okamura, Neurogenic and Endothelial Nitric Oxide Regulates Blood Circulation in Lingual and Other Oral Tissues, Journal of Cardiovascular Pharmacology, 2012, 60, 1, 100

    CrossRef

  12. 12
    Tony W. Ho, Andrew P. Ho, Bernard R. Chaitman, Constance Johnson, Ninan T. Mathew, James Kost, Xiaoyin Fan, Sheena K. Aurora, Jan L. Brandes, Kaiyin Fei, Louise Beebe, Christopher Lines, Mitchell W. Krucoff, Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease, Headache: The Journal of Head and Face Pain, 2012, 52, 2
  13. 13
    R. Nassini, S. Materazzi, J. Vriens, J. Prenen, S. Benemei, G. De Siena, G. la Marca, E. Andre, D. Preti, C. Avonto, L. Sadofsky, V. Di Marzo, L. De Petrocellis, G. Dussor, F. Porreca, O. Taglialatela-Scafati, G. Appendino, B. Nilius, P. Geppetti, The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system, Brain, 2012, 135, 2, 376

    CrossRef

  14. 14
    Saurabh Gupta, Stephanie J. Nahas, B. Lee Peterlin, Chemical Mediators of Migraine: Preclinical and Clinical Observations, Headache: The Journal of Head and Face Pain, 2011, 51, 6
  15. 15
    Martin O. Behm, Rebecca L. Blanchard, M. Gail Murphy, John S. Palcza, Dawn E. Harris, Kristin L. Butterfield, William B. Smith, Richard A. Preston, Jeffrey A. Chodakewitz, Mitchell W. Krucoff, Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study, Headache: The Journal of Head and Face Pain, 2011, 51, 6
  16. 16
    Aisah A Aubdool, Susan D Brain, Neurovascular Aspects of Skin Neurogenic Inflammation, Journal of Investigative Dermatology Symposium Proceedings, 2011, 15, 1, 33

    CrossRef

  17. 17
    Kayi Y. Chan, Steve Vermeersch, Jan de Hoon, Carlos M. Villalón, Antoinette MaassenVanDenBrink, Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects, Pharmacology & Therapeutics, 2011, 129, 3, 332

    CrossRef

  18. You have full text access to this OnlineOpen article18
    Bart J. Van der Schueren, Rebecca Blanchard, M. Gail Murphy, John Palcza, Inge De Lepeleire, Anne Van Hecken, Marleen Depré, Jan N. de Hoon, The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men, British Journal of Clinical Pharmacology, 2011, 71, 5